Key result
Intravenous dodecafluoropentane produced enhanced backscatter in 100% of patients for a mean of 8.4 minutes, improving color flow and Doppler signal detection in areas of sonographic shadowing in 6 patients.
Why the study?
Does dodecafluoropentane ultrasonic contrast enhancement improve diagnostic efficacy in patients with common carotid artery bifurcation disease compared to saline?
Population
16 patients with common carotid artery bifurcation disease
Comparison
Dodecafluoropentane intravenous injection vs Saline injection
Design
Cohort
Follow-up
4 to 20 min
Authors
Loading...
May aid carotid ultrasound visualization; leaves open clinical adoption pending randomized validation.
Does dodecafluoropentane ultrasonic contrast enhancement improve diagnostic efficacy in patients with common carotid artery bifurcation disease compared to saline?
Dodecafluoropentane ultrasonic contrast enhancement improves color flow and Doppler signal detection in carotid artery evaluation, particularly in areas of sonographic shadowing.
Gahn et al. (1999) studied Common carotid artery bifurcation disease (n=16). Dodecafluoropentane vs. Saline injection was evaluated on Enhanced backscatter. Intravenous dodecafluoropentane produced enhanced backscatter in 100% of patients for a mean of 8.4 minutes, improving color flow and Doppler signal detection in areas of sonographic shadowing in 6 patients.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: